serw-MX  [xml]  
 
    
 DeCS Categories

C15 Hemic and Lymphatic Diseases .
C15.378 Hematologic Diseases .
C15.378.190 Bone Marrow Diseases .
C15.378.190.636 Myeloproliferative Disorders .
C15.378.190.636.765 Primary Myelofibrosis .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.500 Clofibric Acid .
D02.241.081.114.968.500.500.195 Clofibrate .
D02.241.081.114.968.500.625 Fenofibrate .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.500 Clofibric Acid .
D02.355.726.305.500.195 Clofibrate .
D02.355.726.305.625 Fenofibrate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.134 Benzophenones .
D02.455.426.559.389.134.750 Fenofibrate .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.500 Clofibric Acid .
D02.455.426.559.389.657.654.305.500.195 Clofibrate .
D02.455.426.559.389.657.654.305.625 Fenofibrate .
D02.522 Ketones .
D02.522.223 Benzophenones .
D02.522.223.750 Fenofibrate .
D03 Heterocyclic Compounds .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.300 Heterocyclic Compounds, 3-Ring .
D03.633.300.240 Dibenzazepines .
D03.633.300.240.520 Lofepramine .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Fenofibrate .
Antara Micronized Procetofen .
Apo-Feno-Micro .
Apo-Fenofibrate .
CiL 8694 .
Controlip .
Fenobeta .
Fenofanton .
Fenofibrat AL .
Fenofibrat AZU .
Fenofibrat AbZ .
Fenofibrat FPh .
Fenofibrat Heumann .
Fenofibrat Hexal .
Fenofibrat Stada .
Fenofibrat-ratiopharm .
Fénofibrate Debat .
Fénofibrate MSD .
Gen-Fenofibrate .
LF-178 .
Lipanthyl .
Lipantil .
Liparison .
Lipidil .
Lipidil-Ter .
Livesan .
Lofibra .
MTW-Fenofibrat .
Normalip .
Novo-Fenofibrate .
Nu-Fenofibrate .
PMS-Fenofibrate Micro .
Phenofibrate .
Procetofene .
Secalip .
Supralip .
Tricor .
durafenat .
fenofibrat von ct .
AZU, Fenofibrat .
Apo Feno Micro .
Apo Fenofibrate .
Debat, Fénofibrate .
Fenofibrat ratiopharm .
Gen Fenofibrate .
Heumann, Fenofibrat .
Hexal, Fenofibrat .
LF 178 .
LF178 .
Lipidil Ter .
MTW Fenofibrat .
Micronized Procetofen, Antara .
Novo Fenofibrate .
Nu Fenofibrate .
PMS Fenofibrate Micro .
Procetofen, Antara Micronized .
Stada, Fenofibrat .
Procetofen .
LIPANTHYL .
An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood. .
1.00
92393
 
Lofepramine .
Deftan .
Feprapax .
Gamanil .
Gamonil .
Leo 640 .
Lofepramine Hydrochloride .
Lomont .
Hydrochloride, Lofepramine .
Lopramine .
A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE. .
0.56
1102
 
Clofibrate .
Athromidin .
Atromid .
Atromid S .
Clofibric Acid, Ethyl Ester .
Ethyl Chlorophenoxyisobutyrate .
Miscleron .
Miskleron .
Chlorophenoxyisobutyrate, Ethyl .
A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) .
0.50
183671
 
Primary Myelofibrosis .
Agnogenic Myeloid Metaplasia .
Bone Marrow Fibrosis .
Chronic Idiopathic Myelofibrosis .
Fibrosis, Bone Marrow .
Idiopathic Myelofibrosis .
Myelofibrosis .
Myelofibrosis With Myeloid Metaplasia .
Myeloid Metaplasia .
Myelosclerosis .
Myelosis, Nonleukemic .
Agnogenic Myeloid Metaplasias .
Bone Marrow Fibroses .
Fibroses, Bone Marrow .
Metaplasia, Agnogenic Myeloid .
Metaplasia, Myeloid .
Metaplasias, Agnogenic Myeloid .
Metaplasias, Myeloid .
Myelofibroses .
Myelofibroses, Primary .
Myelofibrosis, Primary .
Myeloid Metaplasia, Agnogenic .
Myeloid Metaplasias .
Myeloid Metaplasias, Agnogenic .
Myeloscleroses .
Myeloses, Nonleukemic .
Nonleukemic Myeloses .
Nonleukemic Myelosis .
Primary Myelofibroses .
Fibrosis, Bone Marrow .
Myeloid Metaplasia .
Agnogenic Myeloid Metaplasia .
Myelosis, Nonleukemic .
Myelofibrosis .
Myelosclerosis .
Bone Marrow Fibrosis .
A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. .
0.37
505242
 
Clofibric Acid .
2-(4-Chlorophenoxy)-2-methylpropionic Acid .
NSC-1149 .
p-Chlorophenoxyisobutyrate .
p-Chlorophenoxyisobutyric Acid .
NSC 1149 .
NSC1149 .
Clofibrinic Acid .
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. .
0.36
111362